Financials Moderna, Inc.

Equities

MRNA

US60770K1079

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 04:00:00 2025-01-10 pm EST			5-day change	1st Jan Change
42.25 ^USD	-2.13%		+0.17%	+1.61%

Jan. 09	Wall Street: ignore Trump's antics and rates	CF
Jan. 09	Health Care Up as Traders Retreat From Risk -- Health Care Roundup	DJ

Projected Income Statement: Moderna, Inc.

income-statement-evolution-chart MODERNA-INC

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	60.21	803.4	18,471	19,263	6,848	3,290	2,943	3,643
Change	-	1,234.34%	2,199.12%	4.29%	-64.45%	-51.96%	-10.54%	23.81%
EBITDA ¹	-514.7	-731.9	13,528	9,768	-3,618	-3,565	-3,265	-2,547
Change	-	42.2%	-	-27.79%	-	1.45%	8.43%	21.98%
EBIT ¹	-545.7	-763.1	13,296	9,420	-4,239	-3,913	-3,740	-2,972
Change	-	39.84%	-	-29.15%	-	7.68%	4.44%	20.53%
Interest Paid ¹	-	24.72	18	-45	297	-65.2	-69.1	-72.3
Earnings before Tax (EBT) ¹	-514.7	-744.5	13,285	9,575	-3,942	-3,545	-3,454	-2,751
Change	-	44.65%	-	-27.93%	-	10.07%	2.55%	20.37%
Net income ¹	-514	-747.1	12,202	8,362	-4,714	-3,556	-3,468	-2,776
Change	-	45.34%	-	-31.47%	-	24.57%	2.49%	19.94%
Announcement Date	2/26/20	2/25/21	2/24/22	2/23/23	2/22/24	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4
Net sales ¹	14.06	8.389	66.35	157.9	570.7	1,937	4,354	4,969	7,211	6,066	4,749	3,364	5,084	1,862	344	1,831	2,811	167	241	1,862	1,060	140.2	113.2	1,341	1,158
Change	-	-40.31%	690.93%	137.99%	261.44%	239.38%	124.78%	14.12%	45.12%	-15.88%	-21.71%	-29.16%	51.13%	-63.38%	-81.53%	432.27%	53.52%	-94.06%	44.31%	672.61%	-43.1%	-86.77%	-19.2%	1,083.95%	-13.64%
EBITDA	-121.6	-	-	-	-	-	-	-	5,488	-	-	-	-	-	-	-	208	-	-1,322	-18	-	-	-	-	-
Change	-	-100%	-	-	-	-	-	-	-	-100%	-	-	-	-	-	-	-	-100%	-	-98.64%	100%	-	-	-	-
EBIT ¹	-130.6	-130.9	-122.1	-235.1	-275	1,266	3,062	3,558	5,410	4,227	2,447	1,166	1,580	-366	-1,867	-2,012	6	-1,266	-1,363	-70	-1,094	-1,253	-1,285	-575.3	-728.4
Change	-	0.23%	-6.67%	92.52%	16.98%	-	141.86%	16.2%	52.05%	-21.87%	-42.11%	-52.35%	35.51%	-	410.11%	7.77%	-	-	7.66%	-94.86%	-1,462.33%	-14.59%	-2.55%	55.24%	-26.62%
Charge d'intérêts ¹	-	-	-	-	4.2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-81	-	-	-	-
Earnings before Tax (EBT) ¹	-124.4	-124.2	-116.6	-232.8	-271	1,260	3,063	3,552	5,410	4,229	2,474	1,217	1,655	-305	-1,749	-1,958	70	-1,165	-1,279	21	-962.8	-1,176	-1,216	-499.4	-698.5
Change	-	-0.2%	-6.12%	99.69%	16.43%	-	143.1%	15.96%	52.31%	-21.83%	-41.5%	-50.81%	35.99%	-	473.44%	11.95%	-	-	9.79%	-	-	-22.16%	-3.34%	58.92%	-39.87%
Net income ¹	-124.2	-124.2	-116.7	-233.6	-272.5	1,221	2,780	3,333	4,868	3,657	2,197	1,043	1,465	79	-1,380	-3,630	217	-1,175	-1,279	13	-1,005	-1,176	-1,216	-499.4	-698.5
Change	-	-0.01%	-6.05%	100.18%	16.63%	-	127.68%	19.89%	46.05%	-24.88%	-39.92%	-52.53%	40.46%	-94.61%	-	163.04%	-	-	8.85%	-	-	-17.08%	-3.34%	58.92%	-39.87%
Announcement Date	2/26/20	5/7/20	8/5/20	10/29/20	2/25/21	5/6/21	8/5/21	11/4/21	2/24/22	5/4/22	8/3/22	11/3/22	2/23/23	5/4/23	8/3/23	11/2/23	2/22/24	5/2/24	8/1/24	11/7/24	-	-	-	-	-

¹USD in Million

Estimates

Forecast Balance Sheet: Moderna, Inc.

balance-sheet-analysis-chart MODERNA-INC

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net Debt ¹	-971	-4,498	-10,128	-9,902	-8,604	-7,589	-4,312	-2,252
Change	-	-563.23%	-325.17%	-197.77%	-186.89%	-188.2%	-156.82%	-152.23%
Announcement Date	2/26/20	2/25/21	2/24/22	2/23/23	2/22/24	-	-	-

¹USD in Million

Estimates

Cash Flow Forecast: Moderna, Inc.

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
CAPEX ¹	31.55	67.45	284	400	707	1,007	294.8	263.4
Change	-	113.75%	321.07%	40.85%	76.75%	42.49%	-70.74%	-10.64%
Free Cash Flow (FCF) ¹	-490.5	1,960	13,336	4,581	-3,825	-3,758	-3,366	-2,585
Change	-	-499.48%	580.57%	-65.65%	-183.5%	-1.75%	-10.44%	-23.19%
Announcement Date	2/26/20	2/25/21	2/24/22	2/23/23	2/22/24	-	-	-

¹USD in Million

Estimates

Forecast Financial Ratios: Moderna, Inc.

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Profitability
EBITDA Margin (%)	-854.85%	-91.1%	73.24%	50.71%	-52.83%	-108.39%	-110.94%	-69.91%
EBIT Margin (%)	-906.38%	-94.99%	71.98%	48.9%	-61.9%	-118.96%	-127.08%	-81.57%
EBT Margin (%)	-854.88%	-92.67%	71.92%	49.71%	-57.56%	-107.76%	-117.39%	-75.5%
Net margin (%)	-853.73%	-92.99%	66.06%	43.41%	-68.84%	-108.1%	-117.83%	-76.19%
FCF margin (%)	-814.7%	243.91%	72.2%	23.78%	-55.86%	-114.24%	-114.37%	-70.95%
FCF / Net Income (%)	95.43%	-262.3%	109.29%	54.78%	81.14%	105.68%	97.06%	93.12%
Profitability
ROA	-28.95%	-16.74%	76.25%	33.1%	-21.29%	-22.33%	-26.1%	-26.19%
ROE	-38%	-39.99%	146.08%	50.27%	-28.59%	-30.49%	-40.41%	-45.14%
Financial Health
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-	-
Debt / Free cash flow	-	-	-	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	52.41%	8.4%	1.54%	2.08%	10.32%	30.62%	10.02%	7.23%
CAPEX / EBITDA (%)	-6.13%	-9.22%	2.1%	4.1%	-19.54%	-28.25%	-9.03%	-10.34%
CAPEX / FCF (%)	-6.43%	3.44%	2.13%	8.73%	-18.48%	-26.81%	-8.76%	-10.19%
Items per share
Cash flow per share ¹	-	5.316	31.6	11.97	-8.162	-9.006	-7.175	-5.658
Change	-	-	494.51%	-62.12%	-168.19%	10.33%	-20.33%	-21.13%
Dividend per Share ¹	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Book Value Per Share ¹	3.187	6.423	35.1	48.54	36.27	27.07	17.96	10.84
Change	-	101.54%	446.47%	38.28%	-25.28%	-25.37%	-33.65%	-39.66%
EPS ¹	-1.55	-1.96	28.29	20.12	-12.33	-9.323	-8.92	-6.996
Change	-	26.45%	-1,543.37%	-28.88%	-161.28%	-24.39%	-4.32%	-21.57%
Nbr of stocks (in thousands)	333,250	395,710	405,450	384,180	381,284	384,818	384,818	384,818
Announcement Date	2/26/20	2/25/21	2/24/22	2/23/23	2/22/24	-	-	-